SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001072613-24-000116
Filing Date
2024-02-09
Accepted
2024-02-09 17:35:11
Documents
1
Group Members
ARCH VENTURE FUND IX OVERAGE, L.P.ARCH VENTURE PARTNERS IX OVERAGE, L.P.ARCH VENTURE PARTNERS IX, L.P.ARCH VENTURE PARTNERS IX, LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND IX, L.P. - GOSSAMER BIO -- SCH 13G/A(#1-EXIT) arch-sch13g_18793.htm SC 13G/A 81767
  Complete submission text file 0001072613-24-000116.txt   83587
Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 773-380-6600
ARCH Venture Fund IX, L.P. (Filed by) CIK: 0001666306 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Subject) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91334 | Film No.: 24616362
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)